HNRG vs. CERE, CNX, HCC, ARCH, METC, AREC, CEIX, BORR, PUMP, and PDS
Should you be buying Hallador Energy stock or one of its competitors? The main competitors of Hallador Energy include Cerevel Therapeutics (CERE), CNX Resources (CNX), Warrior Met Coal (HCC), Arch Resources (ARCH), Ramaco Resources (METC), American Resources (AREC), CONSOL Energy (CEIX), Borr Drilling (BORR), ProPetro (PUMP), and Precision Drilling (PDS).
Cerevel Therapeutics (NASDAQ:CERE) and Hallador Energy (NASDAQ:HNRG) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, community ranking, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.
87.7% of Cerevel Therapeutics shares are held by institutional investors. Comparatively, 61.4% of Hallador Energy shares are held by institutional investors. 5.1% of Cerevel Therapeutics shares are held by company insiders. Comparatively, 32.3% of Hallador Energy shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
In the previous week, Cerevel Therapeutics had 1 more articles in the media than Hallador Energy. MarketBeat recorded 4 mentions for Cerevel Therapeutics and 3 mentions for Hallador Energy. Hallador Energy's average media sentiment score of 1.13 beat Cerevel Therapeutics' score of 0.28 indicating that Cerevel Therapeutics is being referred to more favorably in the media.
Hallador Energy has higher revenue and earnings than Cerevel Therapeutics.
Hallador Energy has a net margin of 3.79% compared to Hallador Energy's net margin of 0.00%. Cerevel Therapeutics' return on equity of 8.49% beat Hallador Energy's return on equity.
Cerevel Therapeutics currently has a consensus price target of $42.67, indicating a potential upside of 3.81%. Hallador Energy has a consensus price target of $11.00, indicating a potential upside of 49.86%. Given Cerevel Therapeutics' higher possible upside, analysts clearly believe Hallador Energy is more favorable than Cerevel Therapeutics.
Cerevel Therapeutics has a beta of 1.46, meaning that its share price is 46% more volatile than the S&P 500. Comparatively, Hallador Energy has a beta of 0.45, meaning that its share price is 55% less volatile than the S&P 500.
Hallador Energy received 86 more outperform votes than Cerevel Therapeutics when rated by MarketBeat users. However, 66.52% of users gave Cerevel Therapeutics an outperform vote while only 60.40% of users gave Hallador Energy an outperform vote.
Summary
Hallador Energy beats Cerevel Therapeutics on 8 of the 15 factors compared between the two stocks.
Get Hallador Energy News Delivered to You Automatically
Sign up to receive the latest news and ratings for HNRG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HNRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Hallador Energy Competitors List
Related Companies and Tools
